Rilpivirine

73 interactions 6 explained in plain English
Also sold as: Edurant Edurant® Juluca® (as a combination product containing dolutegravir, rilpivirine)
About Rilpivirine

Rilpivirine is used along with other medications to treat human immunodeficiency virus type 1 (HIV-1) in certain adults and children 12 years of age and older who weigh at least 77 lb (35 kg) and have not received antiretroviral treatment in the past. It is also used along with cabotegravir (Vocabria) as a short-term t… Read the full Rilpivirine drug information page →

Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jun 30, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Major

Rilpivirine Abametapir Explained Increased exposure of CYP3A4 substrate Details Rilpivirine Amitriptyline Elavil Explained An increased risk of QT interval prolongation and torsade de pointes Details Rilpivirine Sertraline Explained An increased risk of QT interval prolongation and torsade de pointes Details Rilpivirine Buprenorphine Belbuca Explained An increased risk of QT interval prolongation and torsade de pointes Details Rilpivirine Relugolix Orgovyx Explained Increased risk of QT interval prolongation Details Rilpivirine Amisulpride Injection Barhemsys An increased risk of QT interval prolongation and torsade de pointes Details Rilpivirine Arsenic Trioxide Trisenox Increased risk of QT-interval prolongation and torsade de pointes Details Rilpivirine Aripiprazole Injection Abilify An increased risk of QT interval prolongation Details Rilpivirine Arsenic Trioxide Injection Trisenox Increased risk of QT-interval prolongation and torsade de pointes Details Rilpivirine Asenapine Transdermal Patch Secuado An increased risk of QT interval prolongation and torsade de pointes Details Rilpivirine Azithromycin AzaSite Increased rilpivirine exposure and an increased risk of QT interval prolongation and torsade de pointes Details Rilpivirine Alfuzosin UroXatral An increased risk of QT interval prolongation and torsade de pointes Details Rilpivirine Anagrelide Agrylin Increased risk of QT interval prolongation Details Rilpivirine Bedaquiline Sirturo An increased risk of QT interval prolongation and torsade de pointes Details Rilpivirine Chloroquine Aralen® An increased risk of QT interval prolongation and torsade de pointes Details Rilpivirine Dasatinib Phyrago An increased risk of QT interval prolongation and torsade de pointes Details Rilpivirine Degarelix Injection Firmagon Increased risk of QT interval prolongation Details Rilpivirine Deutetrabenazine Austedo An increased risk of QT interval prolongation and torsade de pointes Details Rilpivirine Disopyramide Norpace An increased risk of QT interval prolongation and torsade de pointes Details Rilpivirine Dofetilide Tikosyn An increased risk of QT interval prolongation and torsade de pointes Details Rilpivirine Dolasetron Anzemet An increased risk of QT interval prolongation and torsade de pointes Details Rilpivirine Dolasetron Injection Anzemet An increased risk of QT interval prolongation and torsade de pointes Details Rilpivirine Encorafenib Braftovi An increased risk of QT interval prolongation and torsade de pointes Details Rilpivirine Entrectinib Rozlytrek An increased risk of QT interval prolongation and torsade de pointes Details Rilpivirine Eribulin Injection Halaven An increased risk of QT interval prolongation and torsade de pointes Details Rilpivirine Famotidine Calmicid Reduced rilpivirine exposure and an increased risk of QT interval prolongation Details Rilpivirine Famotidine Injection Calmicid Reduced rilpivirine exposure and an increased risk of QT interval prolongation Details Rilpivirine Felbamate Felbatol An increased risk of QT interval prolongation and torsade de pointes Details Rilpivirine Flecainide Tambocor® An increased risk of QT interval prolongation and torsade de pointes Details Rilpivirine Foscarnet Injection Foscavir An increased risk of QT interval prolongation and torsade de pointes Details Rilpivirine Galantamine Razadyne An increased risk of QT interval prolongation and torsade de pointes Details Rilpivirine Gatifloxacin Ophthalmic Zymar® An increased risk of QT interval prolongation and torsade de pointes Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.